MANIPALHOS Share Price | Manipal Health Enterprises Ltd Stock Analysis & Recommendation

Q: What does Manipal Health do?

Overview: Manipal Health Enterprises Ltd operates in the hospital industry and is categorized as a large-cap company.History: The incorporation year is not provided, and there are no status changes mentioned. The latest quarter for which sales and profit are reported is June 2026.Financial Snapshot: Most recent Net Sales: 3,091 Cr (Quarterly Results - Jun 2026) Most recent Net Profit: 232 Cr (Quarterly Results - Jun 2026) Market-cap value: INR 102,731 Cr (Large Cap)Key Metrics: P/E: 106.00 Industry P/E: 67 Dividend Yield: 0.00% Debt-Equity: 0.94 Return on Equity: 11.37% Price-to-Book: 12.18 Contact Details: Registrar Address: Not available. Phone: N/A Email: N/A Website: N/A

Q: Who are the peers of the Manipal Health?

Peers: The peers of Manipal Health are Apollo Hospitals, Max Healthcare, Fortis Health., Aster DM Quality, Global Health, Narayana Hrudaya, Krishna Institu., Dr Agarwal's Hea, and Rainbow Child.Quality Snapshot: Excellent management risk is observed at Apollo Hospitals, Narayana Hrudaya, Global Health, and the rest. Good management risk is found at Aster DM Quality, Krishna Institu., Rainbow Child., while Average management risk is present at Max Healthcare, Fortis Health., and Dr Agarwal's Hea. Excellent growth is noted at Apollo Hospitals and Narayana Hrudaya, while Good growth is seen at Fortis Health., Dr Agarwal's Hea, and the rest. Below Average growth is reported at Aster DM Quality, Krishna Institu., and Rainbow Child. Average capital structure is found at Aster DM Quality and Manipal Health, while Good capital structure is observed at Fortis Health., Narayana Hrudaya, Krishna Institu., Dr Agarwal's Hea, and the rest. Excellent capital structure is noted at Max Healthcare and Global Health.Return Snapshot: The peer with the highest 1-year return is Aster DM Quality at 25.77%, while the peer with the lowest is Max Healthcare at -11.72%. Manipal Health's 1-year return is not available for comparison. Additionally, Fortis Health., Max Healthcare, and Rainbow Child. have negative six-month returns.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

33.68 k (-60.26%) Volume

Shareholding (Aug 2026)

FII

3.65%

Held by 80 FIIs

DII

5.46%

Held by 30 DIIs

Promoter

72.08%

Which are the latest news on Manipal Health?

19-Sep-2026

When is the next results date for Manipal Health?

Why is Manipal Health Enterprises Ltd falling/rising?

06-Sep-2026

As of 05-Sep, Manipal Health Enterprises Ltd's stock price is rising to 729.75, driven by strong sector performance, increased investor participation, and favorable long-term moving averages. The stock has outperformed its sector today and shows significant trading activity, indicating heightened investor interest.

View full answer

What does Manipal Health do?

01-Sep-2026

Manipal Health Enterprises Ltd is a large-cap company in the hospital industry, reporting net sales of ₹3,091 Cr and a net profit of ₹232 Cr for June 2026. Key metrics include a P/E ratio of 106.00 and a debt-equity ratio of 0.94.

View full answer

Who are the peers of the Manipal Health?

01-Sep-2026

Peers of Manipal Health include Apollo Hospitals, Max Healthcare, Fortis Health, Aster DM Quality, Global Health, Narayana Hrudaya, Krishna Institute, Dr. Agarwal's Health, and Rainbow Child. Apollo Hospitals and Narayana Hrudaya show excellent management and growth, while Aster DM Quality has the highest 1-year return at 25.77%, and Max Healthcare has the lowest at -11.72%.

View full answer

How big is Manipal Health?

01-Sep-2026

As of 31st August, Manipal Health Enterprises Ltd has a market capitalization of 102,731.00 Cr, with recent Net Sales of 8,210.61 Cr and a Net Profit of 659.67 Cr.

View full answer

When is the next results date for Manipal Health?

17-Aug-2026

Manipal Health will announce its results on 20 August 2026.

View full answer

Compare Manipal Health with Similar Stocks

Max Healthcare Fortis Health.Apollo Hospitals

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Hospital

Market cap

INR 97,463 Cr (Large Cap)

P/E

102.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.94

Return on Equity

11.37%

Price to Book

11.37

Revenue and Profits:

Net Sales:

3,091 Cr

(Quarterly Results - Jun 2026)

Net Profit:

232 Cr

Total Returns

Total Returns (Price + Dividend)

Company does not have enough history

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

When is the next results date for Manipal Health?

Manipal Health will declare its results on 20 August 2026....

Read full news article

Announcements

Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)

16-Sep-2026 | Source : BSE

Intimation pursuant to Regulation 30 (12) read with Schedule III of the SEBI Listing Regulations.

Announcement under Regulation 30 (LODR)-Newspaper Publication

05-Sep-2026 | Source : BSE

Newspaper Advertisement for information regarding the dispatch of the 16th AGM Notice and other related information including e-voting.

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

04-Sep-2026 | Source : BSE

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on September 03 2026 for Manipal Global Health Services & others

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

2.70

Debt to EBITDA (avg)

3.14

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.66

Tax Ratio

22.20%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

9.11%

ROCE (avg)

15.37%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

102

Industry P/E

Price to Book Value

11.61

EV to EBIT

54.28

EV to EBITDA

40.15

EV to Capital Employed

6.48

EV to Sales

10.14

PEG Ratio

Dividend Yield

ROCE (Latest)

11.93%

ROE (Latest)

11.37%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

Bollinger Bands

KST

Dow Theory

OBV

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Aug 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 22 Schemes (3.53%)

FIIs

Held by 80 FIIs (3.65%)

Promoter with highest holding

Kangto Investments Pte. Ltd. (23.73%)

Highest Public shareholder

Tpg Sg Magazine Pte. Ltd. (9.1%)

Individual Investors Holdings

2.33%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 8.42% vs 18.20% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 25.55% vs -26.93% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,048.30",
          "val2": "966.93",
          "chgp": "8.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "250.05",
          "val2": "222.75",
          "chgp": "12.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "61.59",
          "val2": "58.42",
          "chgp": "5.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-13.43",
          "val2": "-10.84",
          "chgp": "-23.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "115.53",
          "val2": "92.02",
          "chgp": "25.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.85%",
          "val2": "23.04%",
          "chgp": "0.81%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,713.05",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,258.12",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "287.68",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-13.28",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "561.47",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.69%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Jun'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,803.68",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,994.73",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "580.95",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-28.75",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "793.12",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.56%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,584.13",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "894.05",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "203.37",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-21.64",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "429.97",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "24.94%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

1,048.30

966.93

8.42%

Operating Profit (PBDIT) excl Other Income

250.05

222.75

12.26%

Interest

61.59

58.42

5.43%

Exceptional Items

-13.43

-10.84

-23.89%

Standalone Net Profit

115.53

92.02

25.55%

Operating Profit Margin (Excl OI)

23.85%

23.04%

0.81%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is 8.42% vs 18.20% in Mar 2026

Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is 25.55% vs -26.93% in Mar 2026

All Quarterly Results

Half Yearly Results Snapshot (Consolidated) - Sep'25

Sep'25

Change(%)

Net Sales

4,713.05

Operating Profit (PBDIT) excl Other Income

1,258.12

Interest

287.68

Exceptional Items

-13.28

Consolidate Net Profit

561.47

Operating Profit Margin (Excl OI)

26.69%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Consolidated) - Jun'26

Jun'26

Change(%)

Net Sales

7,803.68

Operating Profit (PBDIT) excl Other Income

1,994.73

Interest

580.95

Exceptional Items

-28.75

Consolidate Net Profit

793.12

Operating Profit Margin (Excl OI)

25.56%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'26

Mar'26

Change(%)

Net Sales

3,584.13

Operating Profit (PBDIT) excl Other Income

894.05

Interest

203.37

Exceptional Items

-21.64

Standalone Net Profit

429.97

Operating Profit Margin (Excl OI)

24.94%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Manipal Health Enterprises Ltd

Manipal Health Enterprises Ltd

Large Cap

Hospital

No Details Available.

Company Coordinates

No Company Details Available